CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
IBN SINA Pharmaceutical Industry Ltd Company Snapshot
IBN SINA Pharmaceutical Industry Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares IBN SINA Pharmaceutical Industry Ltd with three other pharmaceutical manufacturers in Asia: Panacea Biotec Ltd of INDIA (2020 sales of 5.39 billion Indian Rupees [US$73.00 million] of which 76% was Formulation), YSP Southeast Asia Holding Bhd of MALAYSIA (297.06 million Malaysian Ringgits [US$70.91 million] of which 85% was Manufacturing), and Dongsung Pharmaceutical Company Limited which is based in KOREA (SOUTH) (87.80 billion Korean Won [US$74.45 million] of which 91% was Pharmaceutical Segment).

Sales Analysis. During the third fiscal quarter of 2021, sales at IBN SINA Pharmaceutical Industry Ltd totalled 1.79 billion Bangladeshi Taka. This is an increase of 16.6% from the 1.54 billion Bangladeshi Taka in sales at the company during the third quarter of 2020. During the first three quarters of 2021, sales totalled 5.40 billion Bangladeshi Taka, which is 17.2% higher than through the first three fiscal quarters of 2020. During the previous 15 quarters, sales at IBN SINA Pharmaceutical Industry Ltd have increased compared with the same quarter in the previous year. IBN SINA Pharmaceutical Industry Ltd reported sales of 6.19 billion Bangladeshi Taka (US$72.75 million) for the fiscal year ending June of 2020. This represents an increase of 17.6% versus 2019, when the company's sales were 5.26 billion Bangladeshi Taka. Sales at IBN SINA Pharmaceutical Industry Ltd have increased during each of the previous five years (and since 2015, sales have increased a total of 96%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
IBN SINA Pharmaceutical Industry Ltd
  Stock Performance Chart for IBN SINA Pharmaceutical Industry Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/23/2021): 269.10
(Figures in Bangladeshi Taka)
1 Week -8.8%   13 Weeks 5.3%  
4 Weeks 9.3%   52 Weeks 10.8%  
 
IBN SINA Pharmaceutical Industry Ltd Key Data:
  Ticker: IBNSINA Country: BANGLADESH
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 6,191,628,639
(Year Ending Jan 2021).
Employees: N/A
  Currency: Bangladeshi Taka Market Cap: 8,407,660,026
  Fiscal Yr Ends: June Shares Outstanding: 31,243,627
  Share Type: ORDINARY Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.